To overcome the current limitation for accurate prostate cancer diagnosis, the authors tried detecting the two distinct types of PSA (complexed PSA (c-PSA) and free PSA (f-PSA)) and measured their ratio for more accurate diagnosis of prostate cancer. This evidence concerns the gene PROS1 and prostate carcinoma.